Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant Read more about Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant
Bellicum Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of the Underwriters’ Option Read more about Bellicum Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of the Underwriters’ Option
Bellicum Pharmaceuticals Prices Initial Public Offering of 7,350,000 Shares of Common Stock Read more about Bellicum Pharmaceuticals Prices Initial Public Offering of 7,350,000 Shares of Common Stock
Bellicum Announces New Director, Executive Management Appointments Read more about Bellicum Announces New Director, Executive Management Appointments
Bellicum Appoints Reid Huber, Ph.D. to Board of Directors Read more about Bellicum Appoints Reid Huber, Ph.D. to Board of Directors
Bellicum Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering Read more about Bellicum Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
Bellicum Pharmaceuticals Announces Commercial Licensing of Ariad’s Argent™ Cell-Signaling Regulation Technology for Development of New Cancer Therapies Read more about Bellicum Pharmaceuticals Announces Commercial Licensing of Ariad’s Argent™ Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Bellicum Pharmaceuticals Announces $3.75 Million in Financing Read more about Bellicum Pharmaceuticals Announces $3.75 Million in Financing
Bellicum Pharmaceuticals Announces Initiation of Phase I-II Clinical Trial of Novel Vaccine for Patients with Advanced Prostate Cancer Read more about Bellicum Pharmaceuticals Announces Initiation of Phase I-II Clinical Trial of Novel Vaccine for Patients with Advanced Prostate Cancer
Bellicum Pharmaceuticals Announces $4.5 Million in New Funding Read more about Bellicum Pharmaceuticals Announces $4.5 Million in New Funding